Santen Pharmaceutical Co.... (SNPHY)

PNK: SNPHY · Real-Time Price · USD

10.42

0.13 (1.31%)

At close: May 01, 2025, 3:29 PM

Santen Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Revenue	301.96B	279.04B	266.26B	249.6B	241.56B	234.03B	224.94B	199.1B	195.29B
Cost of Revenue	123.26B	112.95B	109.67B	98.22B	94.83B	90.76B	86.38B	74.97B	72.83B
Gross Profit	178.71B	166.09B	156.59B	151.38B	146.72B	143.26B	138.56B	124.13B	122.46B
Operating Income	38.54B	-3.09B	35.89B	12.92B	33.53B	45.1B	38.69B	32.48B	80.18B
Interest Income	1.57B	1.15B	2.54B	1.35B	950M	901M	1B	909M	782M
Pretax Income	29.87B	-5.8B	35.62B	12.42B	32.09B	43.12B	39.26B	31.82B	79.47B
Net Income	26.64B	-14.95B	27.22B	6.83B	23.62B	31.95B	35.26B	21.72B	53.37B
Selling & General & Admin	91.53B	96.26B	84.5B	79.55B	73.36B	71.27B	68.79B	62.19B	59.41B
Research & Development	25.42B	28.3B	26.38B	24.11B	23.34B	23.76B	24.4B	22.79B	19.99B
Other Expenses	23.22B	n/a	9.82B	34.8B	16.49B	3.13B	6.69B	6.67B	-37.11B
Operating Expenses	140.17B	169.18B	120.7B	138.47B	113.19B	98.16B	99.87B	91.65B	42.28B
Interest Expense	2.66B	1.5B	1.21B	1.49B	2.39B	2.88B	434M	1.56B	1.49B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.95B	15.24B
Cost & Expenses	263.42B	282.13B	230.37B	236.69B	208.02B	188.93B	186.25B	166.62B	115.11B
Income Tax Expense	3.17B	9.18B	8.43B	5.77B	10.38B	11.17B	4B	8.77B	26.1B
Shares Outstanding (Basic)	366.89M	387.42M	399.77M	399.46M	399.16M	406.17M	406.42M	410.34M	413.79M
Shares Outstanding (Diluted)	368.14M	387.42M	400.46M	400.39M	400.25M	407.4M	407.87M	411.88M	415.65M
EPS (Basic)	72.62	-38.58	68.07	17.10	59.16	78.67	86.76	52.96	128.99
EPS (Diluted)	72.37	-38.58	67.97	17.06	59.01	78.43	86.45	52.76	128.41
EBITDA	50.72B	12.95B	52.93B	30.67B	56.43B	52.36B	49.7B	42.79B	45.67B
EBIT	32.54B	-4.3B	36.83B	13.18B	34.48B	46B	39.7B	33.58B	80.96B
Depreciation & Amortization	18.18B	17.25B	17.05B	17.92B	16.57B	10.97B	10.9B	9.88B	9.34B